Metraipolis › archive › dc_3f015e1cc5aa

CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus‑associated B cell diseases — Europe PMC PMID:42191836

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42191836
DOI
10.1038/s41598-[numero omesso]-5
License (as archived)
solo-consultazione
Archived
2026-10-06T10:22:44.280Z
SHA-256 of the archived text
d92735dda2462f617402fcfa8503cbccb06b6a618eea9e8a20239dfbeb8e44cd
Stable URL of this page
https://metraipolis.com/documento/dc_3f015e1cc5aa

How to cite

CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus‑associated B cell diseases — Europe PMC PMID:42191836 — Europe PMC (en), https://europepmc.org/article/MED/42191836 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f015e1cc5aa (Metraipolis archive dc_3f015e1cc5aa, sha256 d92735dda2462f617402fcfa8503cbccb06b6a618eea9e8a20239dfbeb8e44cd)
BibTeX
@misc{dc3f015e1cc5aa,
  title = {CD80 (B7-1) as a potential therapeutic target in Epstein-Barr virus‑associated B cell diseases — Europe PMC PMID:42191836},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42191836},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f015e1cc5aa; sha256 d92735dda2462f617402fcfa8503cbccb06b6a618eea9e8a20239dfbeb8e44cd},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42191836. Agents can read the archived copy with the MCP tool read_document.